[1]
Zivot A,Lipton JM,Narla A,Blanc L, Erythropoiesis: insights into pathophysiology and treatments in 2017. Molecular medicine (Cambridge, Mass.). 2018 Mar 23 [PubMed PMID: 30134792]
[2]
Bernaudin F,Verlhac S,Peffault de Latour R,Dalle JH,Brousse V,Petras E,Thuret I,Paillard C,Neven B,Galambrun C,Divialle-Doumdo L,Pondarré C,Guitton C,Missud F,Runel C,Jubert C,Elana G,Ducros-Miralles E,Drain E,Taïeb O,Arnaud C,Kamdem A,Malric A,Elmaleh-Bergès M,Vasile M,Leveillé E,Socié G,Chevret S, Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia. JAMA. 2019 Jan 22 [PubMed PMID: 30667500]
[3]
Krishnamurti L,Neuberg DS,Sullivan KM,Kamani NR,Abraham A,Campigotto F,Zhang W,Dahdoul T,De Castro L,Parikh S,Bakshi N,Haight A,Hassell KL,Loving R,Rosenthal J,Smith SL,Smith W,Spearman M,Stevenson K,Wu CJ,Wiedl C,Waller EK,Walters MC, Bone Marrow Transplantation for Adolescents and Young Adults with Sickle Cell Disease: Results of a Prospective Multicenter Pilot Study. American journal of hematology. 2019 Jan 13 [PubMed PMID: 30637784]
[4]
Alonso L,González-Vicent M,Belendez C,Badell I,Sastre A,Rodríguez-Villa A,Bermúdez-Cortés M,Hladun R,Díaz de Heredia C, Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON). Medicina clinica. 2019 Feb 15 [PubMed PMID: 30001893]
[5]
Brennan-Cook J,Bonnabeau E,Aponte R,Augustin C,Tanabe P, Barriers to Care for Persons With Sickle Cell Disease: The Case Manager's Opportunity to Improve Patient Outcomes. Professional case management. 2018 Jul/Aug [PubMed PMID: 29846351]
[6]
Kato GJ,Piel FB,Reid CD,Gaston MH,Ohene-Frempong K,Krishnamurti L,Smith WR,Panepinto JA,Weatherall DJ,Costa FF,Vichinsky EP, Sickle cell disease. Nature reviews. Disease primers. 2018 Mar 15 [PubMed PMID: 29542687]
[7]
Frangoul H,Evans M,Isbell J,Bruce K,Domm J, Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide. Bone marrow transplantation. 2018 May [PubMed PMID: 29339800]
[8]
Bernaudin F,Pondarré C,Galambrun C,Thuret I, Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia. Advances in experimental medicine and biology. 2017 [PubMed PMID: 29127678]
[9]
Rangarajan HG,Abu-Arja R,Pai V,Guilcher GMT,Soni S, Outcomes of Unrelated Donor Stem Cell Transplantion with Post-Transplant Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Patients with Severe Sickle Cell Disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Feb [PubMed PMID: 29061531]
[10]
Arnold SD,Brazauskas R,He N,Li Y,Aplenc R,Jin Z,Hall M,Atsuta Y,Dalal J,Hahn T,Khera N,Bonfim C,Majhail NS,Diaz MA,Freytes CO,Wood WA,Savani BN,Kamble RT,Parsons S,Ahmed I,Sullivan K,Beattie S,Dandoy C,Munker R,Marino S,Bitan M,Abdel-Azim H,Aljurf M,Olsson RF,Joshi S,Buchbinder D,Eckrich MJ,Hashmi S,Lazarus H,Marks DI,Steinberg A,Saad A,Gergis U,Krishnamurti L,Abraham A,Rangarajan HG,Walters M,Lipscomb J,Saber W,Satwani P, Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases. Haematologica. 2017 Nov [PubMed PMID: 28818869]
[11]
Urbinati F,Wherley J,Geiger S,Fernandez BC,Kaufman ML,Cooper A,Romero Z,Marchioni F,Reeves L,Read E,Nowicki B,Grassman E,Viswanathan S,Wang X,Hollis RP,Kohn DB, Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease. Cytotherapy. 2017 Sep [PubMed PMID: 28733131]
[12]
Connor JL Jr,Minniti CP,Tisdale JF,Hsieh MM, Sickle Cell Anemia and Comorbid Leg Ulcer Treated With Curative Peripheral Blood Stem Cell Transplantation. The international journal of lower extremity wounds. 2017 Mar [PubMed PMID: 28682672]
[13]
Uchida N,Fujita A,Hsieh MM,Bonifacino AC,Krouse AE,Metzger ME,Donahue RE,Tisdale JF, Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD Patients. Human gene therapy. Clinical development. 2017 Sep [PubMed PMID: 28447889]